• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌中的基质金属蛋白酶系统

The matrix metalloproteinase system in oral squamous cell carcinoma.

作者信息

Baker E A, Leaper D J, Hayter J P, Dickenson A J

机构信息

Professorial Unit of Surgery, University Hospital of North Tees, Stockton on Tees TS19 8PE, UK.

出版信息

Br J Oral Maxillofac Surg. 2006 Dec;44(6):482-6. doi: 10.1016/j.bjoms.2005.10.005. Epub 2005 Dec 9.

DOI:10.1016/j.bjoms.2005.10.005
PMID:16338034
Abstract

BACKGROUND

The matrix metalloproteinase (MMP) system is responsible for degradation of tissue in both normal and pathological processes, including tumour invasion and metastasis.

AIM

To compare tissue concentrations of components of the MMP system between tumour tissue and normal tissue in patients with oral squamous cell carcinoma, and to correlate concentrations with pathological grade of tumour.

METHODS

Thirty-eight paired tissue samples from tumours and normal tissue were analysed by three laboratory techniques: firstly, enzyme linked immunosorbent assays (ELISA) in ng/mg protein for MMP-1, MMP-3, and tissue inhibitors of metalloproteinases (TIMPs) -1 and -2. Secondly, gelatinase activity assays to measure concentrations of total and endogenous active gelatinases, MMP-2 and MMP-9 (ng/mg protein). And thirdly to use quenched fluorescent substrate hydrolysis to measure total MMP activity (pM/min).

RESULTS

The concentration of all MMPs was significantly higher in tumour than in normal oral tissue (p < 0.05, Mann-Whitney U-test). Tissue concentrations of some of these factors correlated with clinical and pathological indices of aggressiveness of tumours, including T-stage, N-stage, tumour differentiation, and anatomical level of involved nodes. However, the study was not powered to show statistical significance.

CONCLUSION

It is the balance between proteinases and their inhibitors that controls tissue degradation at each stage of tumour invasion and metastasis. Measurement of MMPs in oral mucosal biopsy samples may establish the invasive potential of tumours at their initial presentation.

摘要

背景

基质金属蛋白酶(MMP)系统在正常和病理过程中均参与组织降解,包括肿瘤侵袭和转移。

目的

比较口腔鳞状细胞癌患者肿瘤组织与正常组织中MMP系统各成分的组织浓度,并将浓度与肿瘤病理分级相关联。

方法

采用三种实验室技术对38对肿瘤组织和正常组织样本进行分析:首先,用酶联免疫吸附测定法(ELISA)以纳克/毫克蛋白为单位检测MMP-1、MMP-3以及金属蛋白酶组织抑制剂(TIMP)-1和-2。其次,采用明胶酶活性测定法测量总明胶酶和内源性活性明胶酶MMP-2和MMP-9的浓度(纳克/毫克蛋白)。第三,使用淬灭荧光底物水解法测量总MMP活性(皮摩尔/分钟)。

结果

所有MMPs在肿瘤组织中的浓度均显著高于正常口腔组织(p < 0.05,曼-惠特尼U检验)。其中一些因子的组织浓度与肿瘤侵袭性的临床和病理指标相关,包括T分期、N分期、肿瘤分化以及受累淋巴结的解剖水平。然而,该研究的样本量不足以显示统计学意义。

结论

蛋白酶及其抑制剂之间的平衡在肿瘤侵袭和转移的每个阶段控制着组织降解。在口腔黏膜活检样本中检测MMPs可能有助于在肿瘤初发时确定其侵袭潜力。

相似文献

1
The matrix metalloproteinase system in oral squamous cell carcinoma.口腔鳞状细胞癌中的基质金属蛋白酶系统
Br J Oral Maxillofac Surg. 2006 Dec;44(6):482-6. doi: 10.1016/j.bjoms.2005.10.005. Epub 2005 Dec 9.
2
Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.基质金属蛋白酶、其组织抑制剂与结直肠癌分期
Br J Surg. 2000 Sep;87(9):1215-21. doi: 10.1046/j.1365-2168.2000.01531.x.
3
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.基质金属蛋白酶-7(MMP-7)和膜型基质金属蛋白酶-1(MT1-MMP)在口腔鳞状细胞癌中的表达作为肿瘤侵袭和预后的预测指标
J Oral Pathol Med. 2007 Aug;36(7):415-24. doi: 10.1111/j.1600-0714.2007.00546.x.
4
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.颞下颌关节骨关节炎患者滑液中的基质金属蛋白酶和金属蛋白酶组织抑制剂
J Orofac Pain. 2000 Winter;14(1):20-30.
5
Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.基质溶素-1(MMP-7)、92kD明胶酶(MMP-9)和金属弹性蛋白酶(MMP-12)在口腔疣状癌和鳞状细胞癌中的差异表达
J Pathol. 2004 Jan;202(1):14-22. doi: 10.1002/path.1479.
6
Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.基质金属蛋白酶-2和基质金属蛋白酶-9在口腔鳞状细胞癌中的表达及临床意义
Oral Oncol. 2005 Mar;41(3):283-93. doi: 10.1016/j.oraloncology.2004.08.013.
7
Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.基质金属蛋白酶及金属蛋白酶组织抑制剂在结核性胸膜炎中的发生情况
Tuberculosis (Edinb). 2001;81(3):203-9. doi: 10.1054/tube.2000.0276.
8
Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.轻、重度颞下颌关节内紊乱滑膜液中的基质金属蛋白酶
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 May;91(5):517-25. doi: 10.1067/moe.2001.115136.
9
Plasminogen activator system in oral squamous cell carcinoma.口腔鳞状细胞癌中的纤溶酶原激活物系统
Br J Oral Maxillofac Surg. 2007 Dec;45(8):623-7. doi: 10.1016/j.bjoms.2007.04.021. Epub 2007 Jun 21.
10
Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.心脏和肺部结节病病变中基质金属蛋白酶及其组织抑制剂:一项免疫组织化学研究
Hum Pathol. 2002 Dec;33(12):1158-64. doi: 10.1053/hupa.2002.129423.

引用本文的文献

1
Biomolecular alterations temporally anticipate microarchitectural modifications of collagen in oral tongue squamous cell carcinoma.生物分子改变在时间上先于口腔舌鳞状细胞癌中胶原蛋白的微结构改变。
iScience. 2024 Jun 17;27(7):110303. doi: 10.1016/j.isci.2024.110303. eCollection 2024 Jul 19.
2
Expression of collagenases (matrix metalloproteinase-1, -8, -13) and tissue inhibitor of metalloproteinase-3 (TIMP-3) in naturally occurring bovine cutaneous fibropapillomas.天然发生的牛皮肤纤维乳头瘤中胶原酶(基质金属蛋白酶-1、-8、-13)和金属蛋白酶组织抑制剂-3(TIMP-3)的表达
Front Vet Sci. 2023 Jan 12;9:1072672. doi: 10.3389/fvets.2022.1072672. eCollection 2022.
3
Estimation of serum and salivary matrix metalloproteinase levels in oral squamous cell carcinoma patients: a systematic review and meta-analysis.
口腔鳞状细胞癌患者血清和唾液基质金属蛋白酶水平的评估:一项系统评价和荟萃分析。
Postepy Dermatol Alergol. 2021 Feb;38(2):106-114. doi: 10.5114/ada.2021.104285. Epub 2021 Mar 10.
4
Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.口腔黏膜下纤维性变和口腔鳞状细胞癌患者唾液基质金属蛋白酶- 12(MMP- 12)水平的评估。
BMC Oral Health. 2021 Apr 23;21(1):205. doi: 10.1186/s12903-021-01571-7.
5
Exploring the Extracellular Regulation of the Tumor Angiogenic Interaction Network Using a Systems Biology Model.使用系统生物学模型探索肿瘤血管生成相互作用网络的细胞外调节
Front Physiol. 2019 Jul 18;10:823. doi: 10.3389/fphys.2019.00823. eCollection 2019.
6
The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment.肿瘤受体异质性对癌症抗血管生成治疗反应的影响。
Integr Biol (Camb). 2018 Apr 23;10(4):253-269. doi: 10.1039/c8ib00019k.
7
The matrix metalloproteinase and insulin-like growth factor system in oral cancer - a prospective clinical study.口腔癌中的基质金属蛋白酶和胰岛素样生长因子系统——一项前瞻性临床研究。
Onco Targets Ther. 2017 Oct 24;10:5099-5105. doi: 10.2147/OTT.S149231. eCollection 2017.
8
Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissue.乳腺肿瘤组织中血小板反应蛋白-1和血管内皮生长因子的预测模型
NPJ Syst Biol Appl. 2016;2:16030-. doi: 10.1038/npjsba.2016.30. Epub 2016 Oct 20.
9
Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.骨激活素通过调节基质金属蛋白酶来调控头颈部鳞状细胞癌的侵袭。
J Cell Physiol. 2018 Jan;233(1):409-421. doi: 10.1002/jcp.25900. Epub 2017 Apr 25.
10
Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.基质金属蛋白酶作为癌症中可控递送的靶点:上调与表达分析
J Control Release. 2017 Aug 10;259:62-75. doi: 10.1016/j.jconrel.2017.01.034. Epub 2017 Jan 31.